Vystar Corporation
US ˙ OTCPK

Introduction

This page provides a comprehensive analysis of the known insider trading history of Meggs Jason M.. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Meggs Jason M. has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:SYNH / Syneos Health Inc - Class A Chief Financial Officer 71,112
US:VYST / Vystar Corporation Director 500,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Meggs Jason M.. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases VYST / Vystar Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in VYST / Vystar Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

VYST / Vystar Corporation Insider Trades
Insider Sales VYST / Vystar Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in VYST / Vystar Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

VYST / Vystar Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Meggs Jason M. as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2023-02-24 2023-02-23 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -2,607 71,112 -3.54 38.25 -99,718 2,720,034
2023-02-24 2023-02-23 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 874 73,719 1.20
2023-02-24 2023-02-23 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 1,401 72,845 1.96
2023-02-24 2023-02-23 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 5,383 71,444 8.15
2023-01-19 2023-01-18 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -866 66,061 -1.29 34.80 -30,137 2,298,923
2023-01-19 2023-01-17 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -2,842 66,927 -4.07 34.76 -98,788 2,326,383
2022-12-19 2022-12-15 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 15,033 69,769 27.46
2022-07-20 2022-07-18 4 SYNH Syneos Health, Inc.
Class A Common Stock 		S - Sale X -7,500 54,736 -12.05 72.81 -546,075 3,985,328
2022-03-04 2022-03-02 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -6,453 62,236 -9.39 80.75 -521,080 5,025,557
2022-03-04 2022-03-02 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 2,513 68,689 3.80
2022-03-04 2022-03-02 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 2,323 66,176 3.64
2022-03-04 2022-03-02 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 9,364 63,853 17.19
2022-01-20 2022-01-18 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 8,890 54,489 19.50
2022-01-20 2022-01-18 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -3,179 45,599 -6.52 86.09 -273,680 3,925,618
2022-01-12 2022-01-10 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -1,700 48,778 -3.37 93.69 -159,273 4,570,011
2022-01-12 2021-12-01 4 SYNH Syneos Health, Inc.
Class A Common Stock 		G - Gift -1,000 50,478 -1.94
2021-09-03 2021-09-03 4 SYNH Syneos Health, Inc.
Class A Common Stock 		S - Sale X -9,223 51,478 -15.19 95.00 -876,185 4,890,410
2021-07-07 2021-07-06 4 SYNH Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) 		M - Exercise -40 0 -100.00
2021-07-07 2021-07-06 4 SYNH Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) 		M - Exercise -620 0 -100.00
2021-07-07 2021-07-06 4 SYNH Syneos Health, Inc.
Class A Common Stock 		S - Sale X -620 60,701 -1.01 90.00 -55,800 5,463,090
2021-07-07 2021-07-06 4 SYNH Syneos Health, Inc.
Class A Common Stock 		M - Exercise X 620 61,321 1.02 46.00 28,520 2,820,766
2021-07-07 2021-07-06 4 SYNH Syneos Health, Inc.
Class A Common Stock 		S - Sale X -40 60,701 -0.07 90.00 -3,600 5,463,090
2021-07-07 2021-07-06 4 SYNH Syneos Health, Inc.
Class A Common Stock 		M - Exercise X 40 60,741 0.07 43.16 1,726 2,621,582
2021-07-02 2021-06-30 4 SYNH Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) 		M - Exercise -2,068 40 -98.10
2021-07-02 2021-06-30 4 SYNH Syneos Health, Inc.
Stock Option (Right to Buy Class A Common Stock) 		M - Exercise -2,600 0 -100.00
2021-07-02 2021-06-30 4 SYNH Syneos Health, Inc.
Class A Common Stock 		S - Sale X -2,600 60,701 -4.11 90.00 -234,000 5,463,090
2021-07-02 2021-06-30 4 SYNH Syneos Health, Inc.
Class A Common Stock 		M - Exercise X 2,600 63,301 4.28 42.88 111,488 2,714,347
2021-07-02 2021-06-30 4 SYNH Syneos Health, Inc.
Class A Common Stock 		S - Sale X -2,068 60,701 -3.29 90.00 -186,120 5,463,090
2021-07-02 2021-06-30 4 SYNH Syneos Health, Inc.
Class A Common Stock 		M - Exercise X 2,068 62,769 3.41 43.16 89,255 2,709,110
2021-04-16 2021-04-15 4 SYNH Syneos Health, Inc.
Class A Common Stock 		S - Sale X -6,000 60,701 -9.00 84.00 -504,000 5,098,884
2021-03-04 2021-03-02 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -2,278 66,701 -3.30 75.50 -171,989 5,035,926
2021-03-04 2021-03-02 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 1,220 68,979 1.80
2021-03-04 2021-03-02 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 2,038 67,759 3.10
2021-02-18 2021-02-16 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -3,475 65,721 -5.02 78.59 -273,100 5,165,013
2021-01-20 2021-01-15 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 13,344 69,196 23.89
2021-01-20 2021-01-15 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -1,367 55,852 -2.39 75.42 -103,099 4,212,358
2021-01-11 2021-01-08 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -1,732 57,219 -2.94 73.59 -127,458 4,210,746
2021-01-07 2021-01-06 4 SYNH Syneos Health, Inc.
Class A Common Stock 		S - Sale X -5,552 58,951 -8.61 72.00 -399,744 4,244,472
2021-01-07 2020-12-22 4 SYNH Syneos Health, Inc.
Class A Common Stock 		G - Gift -1,500 64,503 -2.27
2020-11-30 2020-11-27 4 SYNH Syneos Health, Inc.
Class A Common Stock 		S - Sale X -4,062 66,003 -5.80 67.00 -272,154 4,422,201
2020-11-25 2020-11-24 4 SYNH Syneos Health, Inc.
Class A Common Stock 		S - Sale X -1,938 70,065 -2.69 67.00 -129,846 4,694,355
2020-11-03 2020-11-01 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -35 72,003 -0.05 55.94 -1,958 4,028,208
2020-04-15 2020-03-05 4 SYNH Syneos Health, Inc.
Performance Restricted Stock Units 		M - Exercise -5,094 7,856 -39.34
2020-04-15 2020-03-05 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 3,115 72,038 4.52
2020-04-15 2020-03-05 4 SYNH Syneos Health, Inc.
Class A Common Stock 		M - Exercise 5,094 68,923 7.98
2020-03-23 2020-03-20 4 SYNH Syneos Health, Inc.
Class A Common Stock 		P - Purchase 45 63,829 0.07 36.00 1,620 2,297,844
2020-03-23 2020-03-20 4 SYNH Syneos Health, Inc.
Class A Common Stock 		P - Purchase 3,510 63,784 5.82 36.75 128,992 2,344,062
2020-02-20 2020-02-18 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -2,680 60,274 -4.26 66.51 -178,247 4,008,824
2020-01-29 2020-01-27 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -380 62,954 -0.60 62.69 -23,822 3,946,586
2020-01-22 2020-01-19 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -129 63,334 -0.20 63.83 -8,234 4,042,609
2020-01-17 2020-01-15 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 13,803 63,463 27.80
2020-01-09 2020-01-08 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -1,732 49,660 -3.37 59.96 -103,851 2,977,614
2019-11-04 2019-11-01 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -23 51,392 -0.04 50.50 -1,162 2,595,296
2019-07-30 2019-07-29 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -157 51,415 -0.30 49.33 -7,745 2,536,302
2019-02-19 2019-02-15 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -2,617 51,572 -4.83 54.74 -143,255 2,823,051
2019-01-29 2019-01-28 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -448 54,189 -0.82 50.25 -22,512 2,722,997
2019-01-23 2019-01-22 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -152 54,637 -0.28 48.79 -7,416 2,665,739
2019-01-09 2019-01-08 4 SYNH Syneos Health, Inc.
Class A Common Stock 		A - Award 16,524 54,789 43.18
2018-12-19 2018-12-17 4 SYNH Syneos Health, Inc.
Class A Common Stock 		P - Purchase 3,650 38,265 10.54 41.25 150,562 1,578,431
2018-11-02 2018-11-01 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -24 34,615 -0.07
2018-07-31 2018-07-30 4 SYNH Syneos Health, Inc.
Class A Common Stock 		F - Taxes -158 34,639 -0.45 48.50 -7,663 1,679,992
2018-05-09 2018-05-07 4 SYNH Syneos Health, Inc.
Performance Restricted Stock Units 		A - Award 12,950 12,950
2018-03-02 3 SYNH Syneos Health, Inc.
Class A Common Stock 		69,594
2018-03-02 3 SYNH Syneos Health, Inc.
Class A Common Stock 		69,594
2015-12-11 2015-12-02 4 VYST Vystar Corp
Director Stock Option (Right to Buy) 		A - Award 500,000 500,000
2015-12-11 3 VYST Vystar Corp
Common Stock 		200,000
2015-12-11 3 VYST Vystar Corp
Common Stock 		200,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)